Related Experiment Video
Updated: Aug 16, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
Spontaneous pneumomediastinum long-term follow-up
Jorge Freixinet1, Francisca García, Pedro M Rodríguez
1Thoracic Surgery Service, University Hospital Dr. Negrín, Barranco de la Ballena s/n, 35020 Las Palmas de Gran Canaria, Canary Islands, Spain. jfregil@gobiernodecanarias.org
Background:
Spontaneous pneumomediastinum (SP) is a rare disorder.
Methods:
The objective of this study is to examine a series of patients treated during 19 years, analyzing risk, clinical, and diagnostic factors as well as treatment and long-term follow-up.
Materials And Methods:
A descriptive, retrospective study was done from 1984 to 2003 on 32 patients admitted to the hospital with SP.
Results:
The average age was 21.4+/-6.1 years, 24 (75%) males. 34.4% had developed some strain before arriving at the hospital. Nine of the cases were asthmatic (28.1%) and another nine were smokers (28.1%). The most frequent complaint was thoracic pain, 25 (78.1%). In the physical examination, subcutaneous cervical emphysema was observed in 25 patients (78.1%). A simple X-ray of the thorax was used in the diagnosis of 32 cases. In two patients, radiological signs of pneumothorax were discovered. An esophagogram was done on two patients but there were no significant findings. All of the cases were treated conservatively. The average hospital stay was 3.2+/-1.6 days. No relapses were noted in the follow-ups.
Conclusion:
SP is an entity that evolves correctly without treatment and has no long-term relapses. Once other occasionally associated entities are ruled out, outpatient management can be employed.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...